Univariate | HR for OS | CI 95% | p-value |
---|---|---|---|
Age > 80 years | 2.22 | 1.07–4.60 | 0.032 |
N+ | 3.68 | 1.52–8.95 | 0.004 |
R+ | 5.38 | 0.70–41.08 | 0.105 |
CCI ≥ 6 | 1.14 | 0.63–2.05 | 0.670 |
KPS ≤ 70% | 1.10 | 0.60–2.00 | 0.763 |
Multivariate | HR for OS | CI 95% | p-value |
---|---|---|---|
Age > 80 years | 1.90 | 0.78–4.65 | 0.159 |
N+ | 3.73 | 1.54–9.03 | 0.004 |
Univariate | HR for LRC | CI 95% | p-value |
---|---|---|---|
Age > 80 years | 0.68 | 0.30–1.52 | 0.351 |
T stage | 1.63 | 0.90–2.96 | 0.108 |
R+ | 2.22 | 0.28–17.8 | 0.454 |
N+ | 3.72 | 1.12–12.3 | 0.031 |
total dose (EQD2) | 0.99 | 0.96–1.02 | 0.496 |
recurrence vs. initial diagnosis | 1.71 | 0.99–2.96 | 0.058 |
KPS ≤ 70% | 0.90 | 0.39–2.06 | 0.803 |